Skip to main content
logo
BioPharma Credit PLC (LON:BPCR)
London flag London · Delayed Price · Currency is GBP · Price in USD
0.9820
+0.0140 (1.45%)
Aug 14, 2026, 4:35 PM GMT

BioPharma Credit Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
129.89122.18108.45182.3184.96
Loss (Gain) From Sale of Investments
-17.520.0923.95-5.9523.75
Other Operating Activities
-0.0400.010.030.02
Change in Accounts Receivable
-21.8-11.48-0.48-9.83-9.8
Change in Accounts Payable
0.561.12-8.7417.71-2.49
Operating Cash Flow
91.1111.91123.18184.2896.44
Operating Cash Flow Growth
-18.60%-9.15%-33.15%91.09%66.06%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Investment in Securities
77.4839.07-1.6648.19-94.82
Investing Cash Flow
77.4839.07-1.6648.19-94.82

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Repurchase of Common Stock
-51.27-105.75-17.22-50.09-
Common Dividends Paid
-79.96-109.02-68.95-95.74-96.17
Financing Cash Flow
-161.65-280.42-106.99-206.62-100.16

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.04-0-0.01-0.03-0.02
Net Cash Flow
6.97-129.4314.5325.82-98.56

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
59.0366.956.88124.0940.26
Unlevered Free Cash Flow
59.0366.956.88124.0940.26

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-21.24-10.36-9.227.88-12.29